Jake June-Koo Lee

23.8k total citations · 1 hit paper
39 papers, 2.9k citations indexed

About

Jake June-Koo Lee is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jake June-Koo Lee has authored 39 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Jake June-Koo Lee's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (14 papers) and Lung Cancer Research Studies (5 papers). Jake June-Koo Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (14 papers) and Lung Cancer Research Studies (5 papers). Jake June-Koo Lee collaborates with scholars based in South Korea, United States and Ethiopia. Jake June-Koo Lee's co-authors include Peter J. Park, Se‐Hoon Lee, Dae Seog Heo, Young Seok Ju, D. Gulhan, Isidro Cortés‐Ciriano, Giorgio Melloni, Tae Min Kim, Joon Kim and Bhumsuk Keam and has published in prestigious journals such as Nature, Cell and JAMA.

In The Last Decade

Jake June-Koo Lee

38 papers receiving 2.9k citations

Hit Papers

Human glioblastoma arises from subventricular zone cells ... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Jake June-Koo Lee
Maria Pik Wong Hong Kong
Peter Kabos United States
Mark R. Lackner United States
Nicolò Riggi Switzerland
Michalina Janiszewska United States
Ranjit S. Bindra United States
Ritu Roy United States
Paul A. Berry United Kingdom
Jake June-Koo Lee
Citations per year, relative to Jake June-Koo Lee Jake June-Koo Lee (= 1×) peers Ajay Pandita

Countries citing papers authored by Jake June-Koo Lee

Since Specialization
Citations

This map shows the geographic impact of Jake June-Koo Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake June-Koo Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake June-Koo Lee more than expected).

Fields of papers citing papers by Jake June-Koo Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake June-Koo Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake June-Koo Lee. The network helps show where Jake June-Koo Lee may publish in the future.

Co-authorship network of co-authors of Jake June-Koo Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jake June-Koo Lee. A scholar is included among the top collaborators of Jake June-Koo Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake June-Koo Lee. Jake June-Koo Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Helena A., Monica F. Chen, Angela Bik‐Yu Hui, et al.. (2024). A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease.. Journal of Clinical Oncology. 42(16_suppl). 8517–8517. 6 indexed citations
2.
Watson, Emma V., Jake June-Koo Lee, D. Gulhan, et al.. (2024). Chromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns. Nature Genetics. 56(5). 900–912. 16 indexed citations
3.
Lee, Jake June-Koo, Youngsook L. Jung, Taek-Chin Cheong, et al.. (2023). ERα-associated translocations underlie oncogene amplifications in breast cancer. Nature. 618(7967). 1024–1032. 62 indexed citations
4.
Li, Li, Pierre Galichon, Xiaoyan Xiao, et al.. (2021). Orphan nuclear receptor COUP‐TFII enhances myofibroblast glycolysis leading to kidney fibrosis. EMBO Reports. 22(6). e51169–e51169. 27 indexed citations
5.
Cortés‐Ciriano, Isidro, D. Gulhan, Jake June-Koo Lee, Giorgio Melloni, & Peter J. Park. (2021). Computational analysis of cancer genome sequencing data. Nature Reviews Genetics. 23(5). 298–314. 65 indexed citations
6.
Kim, Jin Hee, Sun‐Young Kong, Yun‐Hee Kim, et al.. (2020). A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis. British Journal of Cancer. 124(1). 290–298. 7 indexed citations
7.
Youk, Jeonghwan, Yohan An, Seongyeol Park, Jake June-Koo Lee, & Young Seok Ju. (2020). The genome-wide landscape of C:G > T:A polymorphism at the CpG contexts in the human population. BMC Genomics. 21(1). 270–270. 18 indexed citations
8.
Yang, Lixing, Jake June-Koo Lee, Semin Lee, et al.. (2019). An enhanced genetic model of colorectal cancer progression history. Genome biology. 20(1). 168–168. 29 indexed citations
9.
Gulhan, D., Jake June-Koo Lee, Giorgio Melloni, Isidro Cortés‐Ciriano, & Peter J. Park. (2019). Detecting the mutational signature of homologous recombination deficiency in clinical samples. Nature Genetics. 51(5). 912–919. 186 indexed citations
10.
Lee, Joo Ho, Jeong Eun Lee, Jee Ye Kahng, et al.. (2018). Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 560(7717). 243–247. 436 indexed citations breakdown →
11.
Lee, Jake June-Koo, Sandra Louzada, Yu An, et al.. (2016). Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Annals of Oncology. 28(4). 890–897. 52 indexed citations
12.
Kim, Jongshin, Hyowon Hong, Min Hwan Kim, et al.. (2015). Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking. Nature Communications. 6(1). 6781–6781. 144 indexed citations
13.
Kim, Min Hwan, Jongshin Kim, Hyowon Hong, et al.. (2015). Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP / TAZ activation. The EMBO Journal. 35(5). 462–478. 197 indexed citations
14.
Seo, Jeong‐Sun, Young Seok Ju, Won‐Chul Lee, et al.. (2012). The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Research. 22(11). 2109–2119. 427 indexed citations
15.
Lee, Jake June-Koo, Tae Min Kim, Youngil Koh, et al.. (2012). Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. Lung Cancer. 77(2). 460–463. 78 indexed citations
16.
Choi, Hongyoon, Jin Chul Paeng, Dong‐Wan Kim, et al.. (2012). Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Lung Cancer. 79(3). 242–247. 59 indexed citations
17.
Lee, Jake June-Koo, Bhumsuk Keam, Tae Min Kim, et al.. (2012). Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study. Supportive Care in Cancer. 21(1). 183–190. 41 indexed citations
18.
Park, Heae Surng, Jake June-Koo Lee, Dong‐Wan Kim, et al.. (2012). Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients. Lung Cancer. 77(2). 288–292. 93 indexed citations
19.
Shin, Dong‐Yeop, Inho Kim, Ki Hwan Kim, et al.. (2011). Acute Lymphoblastic Leukemia in Elderly Patients: A Single Institution's Experience. The Korean Journal of Internal Medicine. 26(3). 328–328. 7 indexed citations
20.
Song, Shuting, Dae‐Woon Eom, Jake June-Koo Lee, et al.. (2007). The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins. International Journal of Gynecological Cancer. 17(4). 858–867.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026